|
Report No. : |
353626 |
|
Report Date : |
04.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
YAMAGUCHI YAKUHIN SHOKAI LTD |
|
|
|
|
Registered Office : |
2-6-8 Fushimimachi Chuoku Osaka 541-0044 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
30.09.2014 |
|
|
|
|
Date of Incorporation : |
January 1958 |
|
|
|
|
Com. Reg. No.: |
1200-01-01091292 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
A trading firm for import, export and wholesale of:
pharmaceuticals, API, intermediates, chemical products, other |
|
|
|
|
No. of Employee : |
27 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
YAMAGUCHI YAKUHIN
SHOKAI LTD
REGD NAME: KK
Yamaguchi Yakuhin Shokai
MAIN OFFICE: 2-6-8
Fushimimachi Chuoku Osaka 541-0044 JAPAN
Tel: 06-6231-6321
Fax: 06-6231-6357
URL: http://www.yamaguchi-net.com
E-Mail
address: (thru the URL)
ACTIVITIES: Import, export, wholesale of
pharmaceuticals, API, intermediates, other
BRANCHES: Tokyo
OVERSEAS: China, Europe, USA, Korea, India (--business
partners)
OFFICERS: SHIGEMASA AKIYOSHI, PRES Masataka Akiyoshi, ch
Yasushi
Akiyoshi, s/mgn dir Kayo Akiyoshi,
dir
Yen
Amount: In million Yen, unless
otherwise stated
SUMMARY: FINANCES FAIR A/SALES Yen 10,076 M
PAYMENTS NO COMPLAINTS CAPITAL Yen 10 M
TREND STEADY WORTH
Yen 1,217 M
STARTED 1958 EMPLOYES 27
TRADING FIRM SPECIALIZING IN
PHARMACEUTICALS.
FINANCIAL SITUATION CONSIDERED
FAIR AND GOOD FOR
ORDINARY BUSINESS ENGAGEMENTS.
The subject company is a trading firm, owned and operated by
the Akiyoshi family, for import, export and wholesale of pharmaceuticals, API,
intermediates, chemical products, other.
Goods are imported from and exported to: USA, Europe, China, India,
Korea, other. Clients include
pharmaceutical mfrs, wholesalers, other.
The sales volume for Sept/2014 fiscal term amounted to Yen
10,076 million, a 4% up from
Yen 9,711 million in the previous term. Exports were robust to China and other S/E
Asian countries. The recurring profit
was posted at Yen 322 million and the net profit at Yen 151 million,
respectively, compared with Yen 330 million recurring profit and Yen 206
million net profit, respectively, a year ago.
For the term that ended Sept 2015 the recurring profit was
projected at Yen 340 million and the net profit at Yen 160 million,
respectively, on a 5% rise in turnover, to Yen 10,580 million. Final results are yet to be released.
The financial situation is considered FAIR and good for
ORDINARY business engagements
Date Registered: Jan 1958
Regd No.: 1200-01-01091292
(Osaka-Chuoku)
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 80,000 shares
Issued:
20,000 shares
Sum: Yen
10 million
Major shareholders (%): Masataka Akiyoshi (51),
Akiyoshi Co (43), Shigemasa Akiyoshi (6)
No. of shareholders: 3
Nothing
detrimental is known as to the commercial morality of executives.
Activities: A trading firm for import, export and
wholesale of: pharmaceuticals, API, intermediates, chemical products, other
(--100%)
Clients: [Mfrs, wholesalers] Mitsubishi Tanabe
Pharma Corp, Taiho Pharmaceutical, Otsuka Pharmaceutical, Amano Enzyme Inc,
Sumitomo Dainippon Pharma, Shionogi & Co, Nippon Zoki Pharmaceutical, Sawai
Pharmaceutical, other
No. of accounts: 350
Domestic
areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Kyowa Hakko Kirin
Co, Ajinomoto Healthy Supply, Sumitomo Dainippon Pharma, Nipro Corp, Otsuka
Pharmaceutical, Tosoh Corp, Eizai Food Chemical, Iwatani Corp, Dai Nippon
Printing Co, other
Payment record: No
complaints
Location:
Business area in Osaka. Office premises
at the caption address are owned and maintained satisfactory.
Resona Bank (Midosuji)
MUFG (Kawaramachi)
Relations: Satisfactory
(In Million Yen)
|
Terms Ending: |
30/09/2015 |
30/09/2014 |
30/09/2013 |
30/09/2012 |
|
|
Annual
Sales |
|
10,580 |
10,076 |
9,711 |
9,324 |
|
Recur.
Profit |
|
340 |
322 |
330 |
258 |
|
Net
Profit |
|
160 |
151 |
206 |
149 |
|
Total
Assets |
|
|
4,500 |
3,874 |
4,004 |
|
Current
Assets |
|
|
3,512 |
2,685 |
2,809 |
|
Current
Liabs |
|
|
3,206 |
2,522 |
2,609 |
|
Net
Worth |
|
|
1,217 |
1,286 |
1,091 |
|
Capital,
Paid-Up |
|
|
10 |
10 |
10 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
5.00 |
3.76 |
4.15 |
0.15 |
|
Current Ratio |
|
.. |
109.54 |
106.46 |
107.67 |
|
N.Worth Ratio |
|
.. |
27.04 |
33.20 |
27.25 |
|
R.Profit/Sales |
|
3.21 |
3.20 |
3.40 |
2.77 |
|
N.Profit/Sales |
|
1.51 |
1.50 |
2.12 |
1.60 |
|
Return On Equity |
|
.. |
12.41 |
16.02 |
13.66 |
Notes:
Forecast (or estimated) figures for the 30/09/2015 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.75 |
|
|
1 |
Rs.99.61 |
|
Euro |
1 |
Rs.70.67 |
|
YEN |
1 |
Rs.0.54 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
TRU |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.